These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 20335525)

  • 1. The role of folate metabolism-related gene polymorphisms in the development of meningiomas.
    Drakos SS; Anifantaki F; Zarros A; Liapi C
    Cancer Genomics Proteomics; 2010; 7(2):105-9. PubMed ID: 20335525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic profiling reveals alternative genetic pathways of meningioma malignant progression dependent on the underlying NF2 status.
    Goutagny S; Yang HW; Zucman-Rossi J; Chan J; Dreyfuss JM; Park PJ; Black PM; Giovannini M; Carroll RS; Kalamarides M
    Clin Cancer Res; 2010 Aug; 16(16):4155-64. PubMed ID: 20682713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional polymorphisms in folate metabolism genes influence the risk of meningioma and glioma.
    Bethke L; Webb E; Murray A; Schoemaker M; Feychting M; Lönn S; Ahlbom A; Malmer B; Henriksson R; Auvinen A; Kiuru A; Salminen T; Johansen C; Christensen HC; Muir K; McKinney P; Hepworth S; Dimitropoulou P; Lophatananon A; Swerdlow A; Houlston R
    Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1195-202. PubMed ID: 18483342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratumoral patterns of clonal evolution in meningiomas as defined by multicolor interphase fluorescence in situ hybridization (FISH): is there a relationship between histopathologically benign and atypical/anaplastic lesions?
    Sayagués JM; Tabernero MD; Maíllo A; Espinosa A; Rasillo A; Díaz P; Ciudad J; López A; Merino M; Gonçalves JM; Santos-Briz A; Morales F; Orfao A
    J Mol Diagn; 2004 Nov; 6(4):316-25. PubMed ID: 15507670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correspondence of tumor localization with tumor recurrence and cytogenetic progression in meningiomas.
    Palma L
    Neurosurgery; 2009 Jun; 64(6):E1206; author reply E1206. PubMed ID: 19487876
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular genetics of meningiomas: from basic research to potential clinical applications.
    Simon M; Boström JP; Hartmann C
    Neurosurgery; 2007 May; 60(5):787-98; discussion 787-98. PubMed ID: 17460514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of material from chromosome arm 1p during malignant progression of meningioma revealed by fluorescent in situ hybridization.
    Ishino S; Hashimoto N; Fushiki S; Date K; Mori T; Fujimoto M; Nakagawa Y; Ueda S; Abe T; Inazawa J
    Cancer; 1998 Jul; 83(2):360-6. PubMed ID: 9669820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correspondence of tumor localization with tumor recurrence and cytogenetic progression in meningiomas.
    Ketter R; Rahnenführer J; Henn W; Kim YJ; Feiden W; Steudel WI; Zang KD; Urbschat S
    Neurosurgery; 2008 Jan; 62(1):61-9; discussion 69-70. PubMed ID: 18300892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.
    Boström J; Meyer-Puttlitz B; Wolter M; Blaschke B; Weber RG; Lichter P; Ichimura K; Collins VP; Reifenberger G
    Am J Pathol; 2001 Aug; 159(2):661-9. PubMed ID: 11485924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Meningiomas: new prognostic factors].
    Sanz Esponera J
    An R Acad Nac Med (Madr); 2007; 124(2):319-32; discussion 330-2. PubMed ID: 18069599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas.
    Leone PE; Bello MJ; de Campos JM; Vaquero J; Sarasa JL; Pestaña A; Rey JA
    Oncogene; 1999 Apr; 18(13):2231-9. PubMed ID: 10327069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic aggressiveness in benign meningiomas with chromosomal instabilities.
    Monleón D; Morales JM; Gonzalez-Segura A; Gonzalez-Darder JM; Gil-Benso R; Cerdá-Nicolás M; López-Ginés C
    Cancer Res; 2010 Nov; 70(21):8426-34. PubMed ID: 20861191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular pathogenesis of meningiomas.
    Perry A; Gutmann DH; Reifenberger G
    J Neurooncol; 2004 Nov; 70(2):183-202. PubMed ID: 15674477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent loss of chromosome 14 in atypical and malignant meningioma: identification of a putative 'tumor progression' locus.
    Menon AG; Rutter JL; von Sattel JP; Synder H; Murdoch C; Blumenfeld A; Martuza RL; von Deimling A; Gusella JF; Houseal TW
    Oncogene; 1997 Feb; 14(5):611-6. PubMed ID: 9053860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meningioma.
    Marosi C; Hassler M; Roessler K; Reni M; Sant M; Mazza E; Vecht C
    Crit Rev Oncol Hematol; 2008 Aug; 67(2):153-71. PubMed ID: 18342535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cranial meningiomas in 411 neurofibromatosis type 2 (NF2) patients with proven gene mutations: clear positional effect of mutations, but absence of female severity effect on age at onset.
    Smith MJ; Higgs JE; Bowers NL; Halliday D; Paterson J; Gillespie J; Huson SM; Freeman SR; Lloyd S; Rutherford SA; King AT; Wallace AJ; Ramsden RT; Evans DG
    J Med Genet; 2011 Apr; 48(4):261-5. PubMed ID: 21278391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple meningiomas: case report and review of the literature.
    Granger A; Sainsbury R; Wilkinson T; MacFarlane M
    J Clin Neurosci; 2000 Mar; 7(2):149-52. PubMed ID: 10844804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple meningioma with different grades of malignancy: case report with genetic analysis applying single-nucleotide polymorphism array and classical cytogenetics.
    Mocker K; Holland H; Ahnert P; Schober R; Bauer M; Kirsten H; Koschny R; Meixensberger J; Krupp W
    Pathol Res Pract; 2011 Jan; 207(1):67-72. PubMed ID: 20926204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutations.
    Reuss DE; Piro RM; Jones DT; Simon M; Ketter R; Kool M; Becker A; Sahm F; Pusch S; Meyer J; Hagenlocher C; Schweizer L; Capper D; Kickingereder P; Mucha J; Koelsche C; Jäger N; Santarius T; Tarpey PS; Stephens PJ; Andrew Futreal P; Wellenreuther R; Kraus J; Lenartz D; Herold-Mende C; Hartmann C; Mawrin C; Giese N; Eils R; Collins VP; König R; Wiestler OD; Pfister SM; von Deimling A
    Acta Neuropathol; 2013 Mar; 125(3):351-8. PubMed ID: 23404370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intracranial meningiomas: I. Epidemiology, aetiology, pathogenesis and prognostic factors].
    Gelabert-González M; Serramito-García R
    Rev Neurol; 2011 Aug; 53(3):165-72. PubMed ID: 21748714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.